Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the relationship between patient reported outcomes
(PROs) and neutropenia (or its complications) in NSCLC subjects receiving chemotherapy with
or without Neulasta® (pegfilgrastim).